Healthcare: Clinical trial inefficiencies and the role of artificial intelligence

CEO Michelle Gallaher features in Stockhead’s ‘On The Bid’ with Oriel Morrison to discuss the role of AI in the future of healthcare.

The group discusses a range of topics, including shortcomings in the global clinical trial market, Opyl’s origins and core focus, the company’s launch of Opin, COVID-19 vaccine predictions, AI applications in healthcare sector and more.

This excerpt is by StockHead. You can find the original video interview here.